AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (July 26, 2002). doi:10.1152/ajplung.00107.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/5/L1110    most recent
00107.2002v2
00107.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Izbicki, G.
Right arrow Articles by Breuer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Izbicki, G.
Right arrow Articles by Breuer, R.

Articles in PresS, published online ahead of print July 19, 2002
Am J Physiol Lung Cell Mol Physiol, 10.1152/ajplung.00107.2002
Submitted on April 10, 2002
Accepted on June 11, 2002

BLEOMYCIN-INDUCED LUNG FIBROSIS IN IL-4 OVER EXPRESSING AND KNOCKOUT MICE

Gabriel Izbicki1, Reuven Or2, Thomas G. Christensen3, Michael J. Segel1, Alan Fine4, Ronald H. Goldstein4*, and Raphael Breuer5

1 Lung Cellular & Molecular Biology Laboratory-Institute of Pulmonology, Hadassah University Hospital and The Hebrew University-Hadassah Medical School, Jerusalem, Israel
2 Bone Marrow Transplantion Department, Hadassah University Hospital and The Hebrew University-Hadassah Medical School, Jerusalem, Israel
3 Mallory Institute of Pathology, Department of Pathology, Boston University School of Medicine and Boston VA Medical Center, Boston, MA, USA
4 Department of Pulmonary, Boston University School of Medicine and Boston VA Medical Center, Boston, MA, USA
5 Lung Cellular & Molecular Biology Laboratory-Institute of Pulmonology, Hadassah University Hospital and The Hebrew University-Hadassah Medical School, Jerusalem, Israel; Mallory Institute of Pathology, Department of Pathology, Boston University School of Medicine and Boston VA Medical Center, Boston, MA, USA; Department of Pulmonary, Boston University School of Medicine and Boston VA Medical Center, Boston, MA, USA

* To whom correspondence should be addressed. E-mail: rgoldstein{at}lung.bumc.bu.edu.

The role of IL-4 in the development of lung fibrosis is as yet unclear. Bleomycin (Bleo) or saline (Sal) was injected intratracheally into 3 groups of C57Bl/6J mice: transgenic animals that overexpressed IL-4 (IL-4 TG) (n = 14), mice with a targeted knockout mutation of the IL-4 gene (IL-4 KO) (n = 11), and wild-type (WILD) (n = 13) mice. At 14 days, lung fibrosis was evaluated by hydroxyproline measurement and by quantitative image analysis of fibrosis fraction and alveolar wall area fraction. BAL cell counts in all Bleo-treated groups demonstrated an increased percentage of lymphocytes with a corresponding decrease in the percentage of macrophages. Comparing Bleo- to Sal-treated controls within each group of mice showed increases in all lung fibrosis parameters in IL-4 KO and WILD, but not in any of the parameters in IL-4 TG mice. The severity of Bleo-induced fibrotic response was decreased in overexpressed IL-4 TG compared with IL-4 KO mice. These data negate a critical pro-fibrotic role for IL-4 in Bleo-induced lung fibrosis.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. Misson, F. Brombacher, M. Delos, D. Lison, and F. Huaux
Type 2 immune response associated with silicosis is not instrumental in the development of the disease
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L107 - L113.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. A. Beamer and A. Holian
Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure
Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L186 - L195.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Arora, Y. Hernandez, J. R. Erb-Downward, R. A. McDonald, G. B. Toews, and G. B. Huffnagle
Role of IFN-{gamma} in Regulating T2 Immunity and the Development of Alternatively Activated Macrophages during Allergic Bronchopulmonary Mycosis
J. Immunol., May 15, 2005; 174(10): 6346 - 6356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Cavarra, F. Carraro, S. Fineschi, A. Naldini, B. Bartalesi, A. Pucci, and G. Lungarella
Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs
Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1186 - L1192.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Cisneros-Lira, M. Gaxiola, C. Ramos, M. Selman, and A. Pardo
Cigarette smoke exposure potentiates bleomycin-induced lung fibrosis in guinea pigs
Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L949 - L956.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2002 by the American Physiological Society.